At the Musculoskeletal New Ventures Conference this week, hosted by the Memphis Bioworks Foundation and MB Venture Parters , a roundtable discussion was held including principals from EDF Ventures, the Vertical Group, and Thomas McNerny & Partners. The conclusion? Investment looks bad for healthcare startups (Outlook Bleak for Investment in Health Care Startups).
With the credit [...]
If you simply compare the average development times of pharmaceuticals, biotech and medical devices, you will see that medical devices demonstrate the shortest time from conception to market (or rejection). Devices, by virtue of providing, in many cases, a simple mechanical function — flatten atherosclerotic plaque against the lumen (angioplasty), keep it there (stents), close [...]
There’s no question that, whatever label you place on its current state of malaise, the U.S. economy is not in good shape.
The question is asked whether health care should remain a safe haven. After all, there is a downward pressure on prices and there is a latent need for serious reform. At this point, let’s [...]
From the January 2008 edition of MedMarkets
As we begin 2008, the economic picture globally and in the U.S. in particular is not very rosy. A consensus is being reached that we are in the early stages of a “recession” and in mid-January the Federal Reserve Board has lowered the prime rate by 3/4 point, [...]
I have to admit that at times I feel like a broken record, repeatedly pointing out the fact that medical technologies — medical devices in particular — are frequently found to be providing clinical solutions to problems that neither drug companies nor biotech companies are able to achieve. It’s a sort of yankee ingenuity made [...]
